Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0001193125-26-386841

Options or other derivatives

  • Chief Financial Officer acquired 258,770 shares (grant or award)
  • Chief Financial Officer returned 258,770 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Wilterding Mark · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-05 Returned to the company : show line 1 in the form Stock Option (right to buy) −258,770 0 D
2026-09-05 Grant or award : show line 2 in the form Stock Option (right to buy) +258,770 258,770 D
Loading xslF345X06/ownership.xml…